Outcomes of hematopoietic stem cell transplantation in patients aged 70 years and older

Devine SM, Owzar K, Blum W, Mulkey F, Stone RM, Hsu JW, et al. Phase II study of allogeneic transplantation for older patients with acute myeloid leukemia in first complete remission using a reduced-intensity conditioning regimen: Results from cancer and leukemia group B 100103 (alliance for clinical trials in oncology)/blood and marrow transplant clinical trial network 0502. J Clin Oncol. 2015;33:4167–75.

Article 
PubMed 
PubMed Central 

Google Scholar 

Belete H, Burns LJ, Shanley R, Nayar M, McClune B, Lazaryan A, et al. Transplantation related toxicity and mortality in older autologous hematopoietic cell transplantation recipients. Am J Hematol. 2017;92:E529–e33.

Article 
PubMed 
PubMed Central 

Google Scholar 

Spellman SR, Xu K, Oloyede T, Ahn KW, Akhtar O, Bolon YT, et al. Current activity trends and outcomes in hematopoietic cell transplantation and cellular therapy – a report from the CIBMTR. Transpl Cell Ther. 2025;31:505–32.

Google Scholar 

Scott BL, Pasquini MC, Logan BRWJ, Devine SM, Porter DL, Maziarz RT, et al. Myeloablative versus reduced-intensity hematopoietic cell transplantation for acute myeloid leukemia and myelodysplastic syndromes. J Clin Oncol. 2017;35:1154–61.

Article 
PubMed 
PubMed Central 

Google Scholar 

Mushtaq MU, Kasaeian A, Amin MK, Alemi H, Khavandgar N, Ur Rehman A, et al. Factors associated with graft-versus-host disease after related donor allogeneic hematopoietic cell transplantation with post-transplant cyclophosphamide-based GvHD prophylaxis. Blood. 2024;144:3517.

Article 

Google Scholar 

Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inf. 2009;42:377–81.

Article 

Google Scholar 

Harris PA, Taylor R, Minor BL, Elliott V, Fernandez M, O’Neal L, et al. The REDCap consortium: Building an international community of software platform partners. J Biomed Inf. 2019;95:103208.

Article 

Google Scholar 

Brunner AM, Kim HT, Coughlin E, Alyea EP 3rd, Armand P, et al. Outcomes in patients age 70 or older undergoing allogeneic hematopoietic stem cell transplantation for hematologic malignancies. Biol Blood Marrow Transpl. 2013;19:1374–80.

Article 

Google Scholar 

Artz A, Logan BR, Saber W, Geller N, Bellach A, Kou J, et al. The composite health risk assessment model (CHARM) to predict 1-year non-relapse mortality (NRM) among older recipients of allogeneic transplantation: a prospective BMT-CTN study 1704. Blood. 2023;142:109.

Article 

Google Scholar 

Munshi PN, Vesole D, Jurczyszyn A, Zaucha JM, St Martin A, Davila O, et al. Age no bar: a CIBMTR analysis of elderly patients undergoing autologous hematopoietic cell transplantation for multiple myeloma. Cancer. 2020;126:5077–87.

Article 
PubMed 
PubMed Central 

Google Scholar 

Backhaus D, Brauer D, Pointner R, Bischof L, Vucinic V, Franke GN, et al. A high hematopoietic cell transplantation comorbidity Index (HCT-CI) does not impair outcomes after non-myeloablative allogeneic stem cell transplantation in acute myeloid leukemia patients 60 years or older. Bone Marrow Transpl. 2023;58:30–8.

Article 
CAS 

Google Scholar